AAAAAA

   
Results: 1-25 | 26-41
Results: 1-25/41
SUPERIORITY OF SEQUENTIAL VERSUS CONCURRENT ADMINISTRATION OF PACLITAXEL WITH ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF 2 PHASE-II TRIALS
Authors: FELIP E MASSUTI B CAMPS C BENITO D ISLA D GONZALEZLARRIBA JL LOPEZCABRERIZO MP SALAMANCA O PUERTOPICA J MOYANO A BASELGA J ROSELL R
Citation: E. Felip et al., SUPERIORITY OF SEQUENTIAL VERSUS CONCURRENT ADMINISTRATION OF PACLITAXEL WITH ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - COMPARISON OF 2 PHASE-II TRIALS, Clinical cancer research, 4(11), 1998, pp. 2723-2728
FGF4 DISSOCIATES ANTI-TUMORIGENIC FROM DIFFERENTIATION SIGNALS OF RETINOIC ACID IN HUMAN EMBRYONAL CARCINOMAS
Authors: MAERZ WJ BASELGA J REUTER VE MELLADO B MYERS ML BOSL GJ SPINELLA MJ DMITROVSKY E
Citation: Wj. Maerz et al., FGF4 DISSOCIATES ANTI-TUMORIGENIC FROM DIFFERENTIATION SIGNALS OF RETINOIC ACID IN HUMAN EMBRYONAL CARCINOMAS, Oncogene, 17(6), 1998, pp. 761-767
LACK OF INCREASED CARDIAC TOXICITY WITH SEQUENTIAL DOXORUBICIN AND PACLITAXEL
Authors: HUDIS C RICCO L SEIDMAN A BASELGA J CURRIE V FENNELLY D GILEWSKI T LEBWOHL D MOYNAHAN M RAPTIS G SURBONE A SKLARIN N YAO TJ KEEFE D NORTON L
Citation: C. Hudis et al., LACK OF INCREASED CARDIAC TOXICITY WITH SEQUENTIAL DOXORUBICIN AND PACLITAXEL, Cancer investigation, 16(2), 1998, pp. 67-71
DOSE-DENSE THERAPY WITH WEEKLY 1-HOUR PACLITAXEL INFUSIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER
Authors: SEIDMAN AD HUDIS CA ALBANEL J TONG W TEPLER I CURRIE V MOYNAHAN ME THEODOULOU M GOLLUB M BASELGA J NORTON L
Citation: Ad. Seidman et al., DOSE-DENSE THERAPY WITH WEEKLY 1-HOUR PACLITAXEL INFUSIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(10), 1998, pp. 3353-3361
A LUMINESCENCE STUDY OF MICROSTRUCTURE DEVELOPMENT AND MELTING CRYSTALLIZATION PROCESSES IN LOW-DENSITY POLYETHYLENE (LDPE)/
Authors: VIGIL MR BRAVO J ATVARS TDZ BASELGA J
Citation: Mr. Vigil et al., A LUMINESCENCE STUDY OF MICROSTRUCTURE DEVELOPMENT AND MELTING CRYSTALLIZATION PROCESSES IN LOW-DENSITY POLYETHYLENE (LDPE)/, Journal of non-crystalline solids, 235, 1998, pp. 554-558
PRO-TUMOR NECROSIS FACTOR-ALPHA PROCESSING ACTIVITY IS TIGHTLY CONTROLLED BY A COMPONENT THAT DOES NOT AFFECT NOTCH PROCESSING
Authors: MERLOSSUAREZ A FERNANDEZLARREA J REDDY P BASELGA J ARRIBAS J
Citation: A. Merlossuarez et al., PRO-TUMOR NECROSIS FACTOR-ALPHA PROCESSING ACTIVITY IS TIGHTLY CONTROLLED BY A COMPONENT THAT DOES NOT AFFECT NOTCH PROCESSING, The Journal of biological chemistry, 273(38), 1998, pp. 24955-24962
RECOMBINANT HUMANIZED ANTI-HER2 ANTIBODY (HERCEPTIN(TM)) ENHANCES THEANTITUMOR-ACTIVITY OF PACLITAXEL AND DOXORUBICIN AGAINST HER2 NEU OVEREXPRESSING HUMAN BREAST-CANCER XENOGRAFTS/
Authors: BASELGA J NORTON L ALBANELL J KIM YM MENDELSOHN J
Citation: J. Baselga et al., RECOMBINANT HUMANIZED ANTI-HER2 ANTIBODY (HERCEPTIN(TM)) ENHANCES THEANTITUMOR-ACTIVITY OF PACLITAXEL AND DOXORUBICIN AGAINST HER2 NEU OVEREXPRESSING HUMAN BREAST-CANCER XENOGRAFTS/, Cancer research, 58(13), 1998, pp. 2825-2831
CYCLOPHOSPHAMIDE, METHOTREXATE, AND CHRONIC ORAL TEGAFUR MODULATED BYFOLINIC ACID IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CARCINOMA
Authors: RIBAS A ALBANELL J SOLECALVO LA GALLARDO E BELLMUNT J VERA R VIDAL R CARULLA J BASELGA J
Citation: A. Ribas et al., CYCLOPHOSPHAMIDE, METHOTREXATE, AND CHRONIC ORAL TEGAFUR MODULATED BYFOLINIC ACID IN THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CARCINOMA, Cancer, 82(5), 1998, pp. 878-885
PD153035, A TYROSINE KINASE INHIBITOR, PREVENTS EPIDERMAL GROWTH-FACTOR RECEPTOR ACTIVATION AND INHIBITS GROWTH OF CANCER-CELLS IN A RECEPTOR NUMBER-DEPENDENT MANNER
Authors: BOS M MENDELSOHN J KIM YM ALBANELL J FRY DW BASELGA J
Citation: M. Bos et al., PD153035, A TYROSINE KINASE INHIBITOR, PREVENTS EPIDERMAL GROWTH-FACTOR RECEPTOR ACTIVATION AND INHIBITS GROWTH OF CANCER-CELLS IN A RECEPTOR NUMBER-DEPENDENT MANNER, Clinical cancer research, 3(11), 1997, pp. 2099-2106
PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER
Authors: HUDIS C RICCIO L HOLMES F SEIDMAN A BASELGA J CURRIE V FENNELLY D GILEWSKI T MOYNAHAN M RAPTIS G SKLARIN N SURBONE A UHLENHOPP M MAICKEL N YAO TJ HELLMAN S USAKEWICZ J HORTOBAGYI G NORTON L
Citation: C. Hudis et al., PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER, European journal of cancer, 33(13), 1997, pp. 2198-2202
FEASIBILITY TRIAL OF HIGH-DOSE 7-DAY CONTINUOUS-INFUSION IFOSFAMIDE GIVEN ON AN OUTPATIENT BASIS
Authors: BELLMUT J ERES N RIBAS A CASADO S ALBANELL J BASELGA J
Citation: J. Bellmut et al., FEASIBILITY TRIAL OF HIGH-DOSE 7-DAY CONTINUOUS-INFUSION IFOSFAMIDE GIVEN ON AN OUTPATIENT BASIS, Cancer chemotherapy and pharmacology, 40(3), 1997, pp. 273-276
PHOTOCHEMICAL SENSING OF SEMICRYSTALLINE MORPHOLOGY IN POLYMERS - PYRENE IN POLYETHYLENE
Authors: VIGIL MR BRAVO J ATVARS TDZ BASELGA J
Citation: Mr. Vigil et al., PHOTOCHEMICAL SENSING OF SEMICRYSTALLINE MORPHOLOGY IN POLYMERS - PYRENE IN POLYETHYLENE, Macromolecules, 30(17), 1997, pp. 4871-4876
PHOTOPHYSICS OF A PYRENE PROBE GRAFTED ONTO SILANIZED GLASS-FIBER SURFACES
Authors: GONZALEZBENITO J CABANELAS JC AZNAR A VIGIL MR BRAVO J SERRANO B BASELGA J
Citation: J. Gonzalezbenito et al., PHOTOPHYSICS OF A PYRENE PROBE GRAFTED ONTO SILANIZED GLASS-FIBER SURFACES, Journal of luminescence, 72-4, 1997, pp. 451-453
VITAMIN-C CROSSES THE BLOOD-BRAIN-BARRIER IN THE OXIDIZED FORM THROUGH THE GLUCOSE TRANSPORTERS
Authors: AGUS DB GAMBHIR SS PARDRIDGE WM SPIELHOLZ C BASELGA J VERA JC GOLDE DW
Citation: Db. Agus et al., VITAMIN-C CROSSES THE BLOOD-BRAIN-BARRIER IN THE OXIDIZED FORM THROUGH THE GLUCOSE TRANSPORTERS, The Journal of clinical investigation, 100(11), 1997, pp. 2842-2848
CARBOPLATIN-BASED VERSUS CISPLATIN-BASED CHEMOTHERAPY IN THE TREATMENT OF SURGICALLY INCURABLE ADVANCED BLADDER-CARCINOMA
Authors: BELLMUNT J RIBAS A ERES N ALBANELL J ALMANZA C BERMEJO B SOLE LA BASELGA J
Citation: J. Bellmunt et al., CARBOPLATIN-BASED VERSUS CISPLATIN-BASED CHEMOTHERAPY IN THE TREATMENT OF SURGICALLY INCURABLE ADVANCED BLADDER-CARCINOMA, Cancer, 80(10), 1997, pp. 1966-1972
5-DAY COURSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH PROLONGED NEUTROPENIA AFTER ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER IS A SAFE AND COST-EFFECTIVE SCHEDULE TO MAINTAIN DOSE-INTENSITY
Authors: RIBAS A ALBANELL J BELLMUNT J SOLECALVO LA BERMEJO B GALLARDO E VIDAL R VERA R ERES N CARULLA J BASELGA J
Citation: A. Ribas et al., 5-DAY COURSE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH PROLONGED NEUTROPENIA AFTER ADJUVANT CHEMOTHERAPY FOR BREAST-CANCER IS A SAFE AND COST-EFFECTIVE SCHEDULE TO MAINTAIN DOSE-INTENSITY, Journal of clinical oncology, 14(5), 1996, pp. 1573-1580
PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/
Authors: BASELGA J TRIPATHY D MENDELSOHN J BAUGHMAN S BENZ CC DANTIS L SKLARIN NT SEIDMAN AD HUDIS CA MOORE J ROSEN PP TWADDELL T HENDERSON IC NORTON L
Citation: J. Baselga et al., PHASE-II STUDY OF WEEKLY INTRAVENOUS RECOMBINANT HUMANIZED ANTI-P185(HER2) MONOCLONAL-ANTIBODY IN PATIENTS WITH HER2 NEU-OVEREXPRESSING METASTATIC BREAST/, Journal of clinical oncology, 14(3), 1996, pp. 737-744
PHASE-II AND PHARMACOLOGICAL STUDY OF DOCETAXEL AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
Authors: HUDIS CA SEIDMAN AD CROWN JPA BALMACEDA C FREILICH R GILEWSKI TA HAKES TB CURRIE V LEBWOHL DE BASELGA J RAPTIS G GOLLUB M ROBLES M BRUNO R NORTON L
Citation: Ca. Hudis et al., PHASE-II AND PHARMACOLOGICAL STUDY OF DOCETAXEL AS INITIAL CHEMOTHERAPY FOR METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(1), 1996, pp. 58-65
SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE
Authors: HUDIS C SEIDMAN A RAPTIS G FENNELLY D GILEWSKI T BASELGA J THEODOULOU M SKLARIN N MOYNAHAN M SURBONE A CURRIE V LEBWOHL D UHLENHOPP M CROWN J NORTON L
Citation: C. Hudis et al., SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 58-64
STUDIES OF POLYMERIZATION OF ACRYLIC-MONOMERS USING LUMINESCENCE PROBES AND DIFFERENTIAL SCANNING CALORIMETRY
Authors: SERRANO B LEVENFELD B BRAVO J BASELGA J
Citation: B. Serrano et al., STUDIES OF POLYMERIZATION OF ACRYLIC-MONOMERS USING LUMINESCENCE PROBES AND DIFFERENTIAL SCANNING CALORIMETRY, Polymer engineering and science, 36(2), 1996, pp. 175-181
EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN HUMAN BREAST-CANCER
Authors: ZAMORALEON SP GOLDE DW CONCHA II RIVAS CI DELGADOLOPEZ F BASELGA J NUALART F VERA JC
Citation: Sp. Zamoraleon et al., EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN HUMAN BREAST-CANCER, Proceedings of the National Academy of Sciences of the United Statesof America, 93(5), 1996, pp. 1847-1852
EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN HUMAN BREAST-CANCER (VOL 93, PG 1847, 1996)
Authors: ZAMORALEON SP GOLDE DW CONCHA II RIVAS CI DELGADOLOPEZ F BASELGA J NUALART F VERA JC
Citation: Sp. Zamoraleon et al., EXPRESSION OF THE FRUCTOSE TRANSPORTER GLUT5 IN HUMAN BREAST-CANCER (VOL 93, PG 1847, 1996), Proceedings of the National Academy of Sciences of the United Statesof America, 93(26), 1996, pp. 15522-15522
AUTOCRINE REGULATION OF MEMBRANE TRANSFORMING GROWTH-FACTOR-ALPHA CLEAVAGE
Authors: BASELGA J MENDELSOHN J KIM YM PANDIELLA A
Citation: J. Baselga et al., AUTOCRINE REGULATION OF MEMBRANE TRANSFORMING GROWTH-FACTOR-ALPHA CLEAVAGE, The Journal of biological chemistry, 271(6), 1996, pp. 3279-3284
SURFACE CHARACTERIZATION OF SILANIZED GLASS-FIBERS BY LABELING WITH ENVIRONMENTAL SENSITIVE FLUOROPHORES
Authors: GONZALEZBENITO J CABANELAS JC AZNAR AJ VIGIL MR BRAVO J BASELGA J
Citation: J. Gonzalezbenito et al., SURFACE CHARACTERIZATION OF SILANIZED GLASS-FIBERS BY LABELING WITH ENVIRONMENTAL SENSITIVE FLUOROPHORES, Journal of applied polymer science, 62(2), 1996, pp. 375-384
COOPERATIVE ANTIPROLIFERATIVE EFFECTS OF 8-CHLORO-CYCLIC AMP AND 528 ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY ON HUMAN CANCER-CELLS
Authors: CIARDIELLO F DAMIANO V BIANCO C DIISERNIA G RUGGIERO A CARAGLIA M TAGLIAFERRI P BASELGA J MENDELSOHN J BIANCO AR TORTORA G
Citation: F. Ciardiello et al., COOPERATIVE ANTIPROLIFERATIVE EFFECTS OF 8-CHLORO-CYCLIC AMP AND 528 ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR MONOCLONAL-ANTIBODY ON HUMAN CANCER-CELLS, Clinical cancer research, 1(2), 1995, pp. 161-167
Risultati: 1-25 | 26-41